BALDUINI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 13.299
AS - Asia 8.784
EU - Europa 6.373
SA - Sud America 1.103
Continente sconosciuto - Info sul continente non disponibili 629
AF - Africa 226
OC - Oceania 25
Totale 30.439
Nazione #
US - Stati Uniti d'America 12.781
CN - Cina 4.571
SG - Singapore 1.769
IE - Irlanda 1.480
HK - Hong Kong 893
UA - Ucraina 811
BR - Brasile 810
VN - Vietnam 724
FI - Finlandia 710
IT - Italia 650
DE - Germania 620
RU - Federazione Russa 585
SE - Svezia 443
FR - Francia 419
GB - Regno Unito 349
CA - Canada 238
IN - India 193
AR - Argentina 120
BD - Bangladesh 109
ZA - Sudafrica 89
IQ - Iraq 79
MX - Messico 66
JP - Giappone 52
NL - Olanda 52
TR - Turchia 47
ID - Indonesia 46
EC - Ecuador 44
PK - Pakistan 38
CO - Colombia 37
PL - Polonia 33
ES - Italia 32
BE - Belgio 31
CR - Costa Rica 29
UZ - Uzbekistan 28
MA - Marocco 27
MY - Malesia 27
SA - Arabia Saudita 27
GT - Guatemala 26
PH - Filippine 24
SV - El Salvador 23
IR - Iran 22
PR - Porto Rico 22
TT - Trinidad e Tobago 22
VE - Venezuela 22
JM - Giamaica 21
EG - Egitto 20
RO - Romania 20
JO - Giordania 19
AT - Austria 18
AU - Australia 18
PY - Paraguay 18
TN - Tunisia 18
HN - Honduras 17
CZ - Repubblica Ceca 16
CL - Cile 15
EU - Europa 15
KE - Kenya 15
NI - Nicaragua 15
PE - Perù 13
AZ - Azerbaigian 12
DK - Danimarca 12
GR - Grecia 12
IL - Israele 12
NP - Nepal 12
UY - Uruguay 12
ET - Etiopia 11
BO - Bolivia 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
AL - Albania 9
CW - ???statistics.table.value.countryCode.CW??? 9
LB - Libano 9
MU - Mauritius 9
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
GP - Guadalupe 8
KR - Corea 8
LT - Lituania 8
BH - Bahrain 7
PA - Panama 7
CH - Svizzera 6
KZ - Kazakistan 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
RS - Serbia 6
BB - Barbados 5
HU - Ungheria 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
CG - Congo 4
CY - Cipro 4
LU - Lussemburgo 4
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GH - Ghana 3
HR - Croazia 3
KW - Kuwait 3
MD - Moldavia 3
OM - Oman 3
Totale 29.771
Città #
Dublin 1.477
San Jose 1.425
Chandler 1.363
Jacksonville 1.161
Ashburn 1.148
Nanjing 1.035
Singapore 900
Hong Kong 873
Council Bluffs 766
Dallas 729
Beijing 621
Boardman 444
Nanchang 419
Princeton 318
Shenyang 304
Changsha 299
Wilmington 294
Medford 292
Lawrence 289
Hebei 287
Lauterbourg 264
Ho Chi Minh City 257
Los Angeles 255
Jiaxing 224
Hanoi 184
Tianjin 175
Hangzhou 166
New York 155
Helsinki 148
Ann Arbor 138
Buffalo 122
Munich 108
Santa Clara 104
Moscow 100
Milan 99
Shanghai 97
São Paulo 82
Redondo Beach 77
Pavia 72
Woodbridge 70
Houston 69
Johannesburg 66
Toronto 59
Orem 54
Tokyo 47
Verona 46
Montreal 45
Atlanta 44
Brooklyn 44
Norwalk 43
Seattle 43
San Francisco 42
Da Nang 41
Frankfurt am Main 41
Turku 41
Chennai 40
Rome 40
Chicago 39
Fairfield 39
Denver 38
Guangzhou 38
Phoenix 33
The Dalles 31
London 30
Brussels 29
Haiphong 28
Mexico City 28
North Bergen 28
Zhengzhou 28
Baghdad 27
Belo Horizonte 27
Brasília 27
Naples 27
Ningbo 26
Warsaw 26
Jinan 25
Tashkent 24
Manchester 22
Ankara 21
Boston 21
Des Moines 21
Dhaka 21
Columbus 20
San Salvador 20
Pune 19
San José 19
Amsterdam 18
Cleveland 18
Guatemala City 18
Mumbai 17
Rio de Janeiro 17
Auburn Hills 16
Biên Hòa 16
Amman 15
Falkenstein 15
Miami 15
Palermo 15
Managua 14
Nuremberg 14
Paris 14
Totale 19.150
Nome #
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 182
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 178
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 172
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 168
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 167
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 165
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 164
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 163
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 158
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 154
Age- And Sex-Related Variations in Platelet Count in Italy: A Proposal of Reference Ranges Based on 40987 Subjects' Data 154
Efficacy of thalidomide in the treatment of severe recurrent epistaxis in hereditary hemorrhagic teleangiectasia: a comparison between HHT1 and 2. 153
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 153
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 150
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 150
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 148
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia 148
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 148
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 146
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 146
Antigeni minori di istocompatibilità 145
Anomalous erythrocytes produced by rabbits with liver damage. 144
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 144
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 143
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 139
Spectrum of the mutations in Bernard-Soulier syndrome. 138
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 138
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 136
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 136
[Non-suppurative recurrent febrile nodular panniculitis (Weber-Christian disease). Description of a case with disseminated intravascular coagulopathy] 136
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 135
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 135
Effect of platelet GP llb-llla complex occupancy on early stages of platelet activation 135
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 134
[Idiopathic myelodysplastic syndromes. A caseload contribution]. 134
Intermittent Flushing with Heparin Versus Saline for Maintenance of Peripheral Intravenous Catheters in a Medical Department: A Pragmatic Cluster-Randomized Controlled Study 134
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 134
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 133
3D silk bone marrow model: a promising tool to test efficacy of new biomimetic drugs on platelet production 133
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 132
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 132
EDA fibronectin–TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis 132
Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine 131
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 129
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 129
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 129
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 129
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 128
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 128
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 128
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 127
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 127
Acute granulocytic leukemia with Alder-Reilly inclusions. 127
A modified technique for therapeutic leukapheresis using a discontinuous flow. 126
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 126
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 125
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 125
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 124
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 122
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 122
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 122
Acquired immune thrombastenia: a new bleeding disorder. 121
Inherited thrombocytopenias. The evolving spectrum. 121
High doses of romiplostim induce proliferation and reduce proplatelet formation by human megakaryocytes 121
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 121
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 120
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 120
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 120
Possible evolution of human parvovirus B19 infection into erythroleukemia 119
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes. 119
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 119
Spontaneous long-lasting remission in a young patient with angioimmunoblastic lymphadenopathy with dysproteinemia. 118
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 118
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 117
Lessons in platelet production from inherited thrombocytopenias. 117
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. 117
Castleman's disease with coagulation defect. A case report. 117
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim 117
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 116
Osteomalacia ipofosfatemica secondaria ad emangiopericitoma sottocutaneo. Studio clinico ed istopatologico di un caso. 116
Structure and"in vitro"function of platelets stored as platelet concentrates at room temperature. 116
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 115
Aggregation of human platelets stimulates calcium ion movement and release reaction. 114
The Case. Proteinuria and low platelet count. 114
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 114
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia 114
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. 113
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 112
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 112
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 112
Bleeding is not the main clinical issue in many patients with inherited thrombocytopaenias 112
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 111
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. 111
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 111
A single cell summarizing the pathogenesis of cytopenias in hemophagocytic syndrome. 111
Acute lymphoblastic leukemia and eosinophilia. 111
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. 111
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 111
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 111
Inherited thrombocytopenias: from genes to therapy. 110
Totale 13.073
Categoria #
all - tutte 130.688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.688


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.303 0 0 0 0 51 51 25 82 70 47 182 795
2022/20234.032 452 242 25 354 398 434 7 209 1.706 24 99 82
2023/20241.250 168 212 42 130 124 334 23 89 9 50 49 20
2024/20253.418 76 337 92 115 56 129 98 251 758 102 413 991
2025/20269.343 705 630 1.188 1.102 1.007 430 1.873 399 761 655 289 304
2026/20272.968 252 547 748 1.318 103 0 0 0 0 0 0 0
Totale 30.439